comparemela.com

Latest Breaking News On - Drug discovery service - Page 1 : comparemela.com

SyntheticGestalt and Enamine to Collaborate on the Creation of AI-Based Model to Facilitate Drug Discovery

/PRNewswire/ SyntheticGestalt, a research and development company specializing in the application of AI to the life sciences domain, and Enamine, the.

Japan
Tokyo
Ukraine
Prnewswire-syntheticgestalt
Koki-shimada
Iaroslava-kos
Syntheticgestalt-drug-discovery-service
Nvidia
Drug-discovery-service
Contract-research-organisation
Business-development-at-enamine
Enamine-ltd

The quantum computing in drug discovery services market is anticipated to grow at 14% CAGR by 2035, according to a market research report by Roots Analysis

The quantum computing in drug discovery services market is anticipated to grow at 14% CAGR by 2035, according to a market research report by Roots Analysis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states
Steigen
Baden-wüberg
Germany
London
City-of
United-kingdom
America
Gaurav-chaudhary
Software-providers
Blockchain-technology-in-healthcare-market
Amazon-web-services

Worldwide Quantum Computing in Drug Discovery Services Industry to 2035: North America is Anticipated to Capture the Highest Market Share by 2035

/PRNewswire/ The "Quantum Computing in Drug Discovery Services Market: Distribution by Drug Discovery Service Offered, Therapeutic Area, and Key.

United-states
Dublin
Ireland
America
Laura-wood
Amazon-web-services
America-peer-group
Ibm
World-peer-group
Microsoft
Europe-peer-group
Huawei

ONCODESIGN Announces the Separation of Its Two Business Lines - Service and Biotech - and Its Entry Into Exclusive Negotiations With Elyan Partners for the Sale of a Majority Stake in ONCODESIGN (Service), Followed by a Simplified Takeover Offer

The planned transactions are as follows: The subsidiarisation by ONCODESIGN of its Biotech/AI activities through a partial transfer of assets to the ONCODESIGN Precision Medicine (OPM) subsidiary

Saclay
France-general
France
United-states
Canada
Paris
French
America
Arthur-rouill
Fabrice-viviani
Mathilde-bohin
Olivier-arthaud

ONCODESIGN Announces the Separation of Its Two Business Lines – Service and Biotech – and Its Entry

The planned transactions are as follows:The subsidiarisation by ONCODESIGN of its Biotech/AI activities through a partial transfer of assets to the ONCODESIGN Precision Medicine (OPM) subsidiary, and the listing of this subsidiary through an exceptional distribution in kind to ONCODESIGN's shareholders concomitant w.

Saclay
France-general
France
United-states
Canada
Paris
French
America
Fabrice-viviani
Mathilde-bohin
Olivier-arthaud
Philippe-genne

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.